◆ 会议时间：2024年3月17日至20日
◆ 会议地点：南非 开普敦

◆ 会议简介：

2024年第13届国际肺炎链球菌和肺炎球菌性疾病研讨会(ISPPD)将于2024年3月17日至20日在南非开普敦举行，会议由国际肺炎链球菌和肺炎球菌性疾病学会(ISPPD)主办。国际肺炎链球菌和肺炎球菌性疾病研讨会（ISPPD）是首屈一指的致力于交流、推广和传播有关基础科学、微生物学、流行病学以及肺炎链球菌和肺炎球菌性疾病治疗与预防的最新发现的全球性科学研讨会。ISPPD提供了一个无与伦比的国际论坛，使科学界、临床和公共卫生专家，从业人员和学生汇聚一堂，以展示、讨论、挑战和学习肺炎球菌性疾病的最新工作成果和进展。

国际肺炎链球菌和肺炎球菌性疾病学会(ISPPD)是一个非营利、非政府组织，总部设在瑞士日内瓦。ISPPD于2012年3月11日在巴西福兹德伊瓜苏举行的ISPPD-8研讨会上正式启动。ISPPD的任务是提高对肺炎球菌生物学、发病机制和流行病学的认识和理解，宿主对肺炎球菌携带和感染的反应；以及肺炎球菌病的预防和治疗。目前，ISPPD协会的主要活动宣是每两年一届的ISPPD国际研讨会，宗旨是汇集对肺炎球菌和肺炎球菌性疾病感兴趣的专业人士，以提高全球意识，并提高诊断、预防和治疗的标准。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

13th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-13)
Date: 17-20 March, 2024
Location: Cape Town, South Africa

摘要征文投稿：

RULES FOR SUBMISSION

• All abstracts must be submitted via this online portal. Please note that the Meeting Organisers are not able to accept abstracts submitted via e-mail.
• Abstracts must be received by the announced deadline (12 September 2023 – 23:59 SAST (South African Standard Time)). Abstracts received after the deadline will not be considered.
• Abstracts must be original and must not have been published or presented at any other international meeting prior to ISPPD-13.
• All abstracts must be submitted in English.
• Each abstract should not exceed 250 words.
• The abstract title should not exceed 25 words and should be UPPER CASE.
• Each author can submit a maximum of five (5) abstracts and each person can be assigned as the presenter of a maximum of five (5) abstracts.

The following structure must be followed when submitting an abstract:

1. Background
2. Methods
3. Results
4. Conclusions

Presentation Type

Please choose the presentation format you would prefer. Please note that the Meeting Organisers will determine the final format based on content and programme time limitations.

• Oral presentation (about 10-minutes including Q&A) in a meeting hall
• Poster presentation with spotlight talk (about 6 minutes including Q&A) at an E-Poster station in the poster area. Spotlight presenters will be requested to both bring a printed poster and submit an E-Poster of their abstract.
• Poster viewing within the on-site poster area. Presenting authors of abstracts selected for poster viewing will be requested to both bring a printed poster and submit an E-Poster for electronic viewing. There will be no designated presentation time for poster viewing. Instead, authors are kindly requested to visit the on-site poster area during longer programming breaks and interact with other delegates.

Basic Information

• Presenting author’s contact details
• Author(s) names appear in upper and lower case (e.g. J.C. Smith).
• Author and co-authors’ affiliation details: department, institution/organisation, city, state (if relevant), country.
• Abstract title – The title is limited to 25 words in UPPER CASE (e.g. EVALUATING VACCINE IMPACT)
• Abstract text – The text is limited to 250 words, including acknowledgments (if any). The text count may be affected by inserting tables and non-scientific text such as acknowledgments.
• Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Programme. Please choose from the list of topics.
• Keywords – Please enter 1 to 5 keywords that define your abstract. The keywords must be in English and can include numbers.
• Images, graphs, tables – The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixels. You may upload images in JPEG/JPG or PNG format only.
• Conflict of interest disclosure – At the time of submission, the submitting author will be requested to provide a brief conflict of interest statement on behalf of all co-authors. If the abstract is selected for presentation, the presenting author will be contacted additionally to complete a mandatory Conflict of Interest Disclosure form.

Dear Colleagues and Friends,

On behalf of the Board and the Local Organising and Scientific Programme Committees, we warmly welcome you to the 13th Meeting of the International Society of Pneumonia and Pneumococcal Diseases (ISPPD-13) in Cape Town, South Africa to be held from 17-20 March 2024 at the beautiful Cape Town International Convention Centre (CTICC). Historically, ISPPD was the premier meeting for pneumococcal researchers globally, bringing together individuals with a diverse range of interests and expertise. Since the COVID-19 pandemic, we recognise the need to expand the content and context of this meeting to include the clinical syndrome of pneumonia more broadly.

This is the second time that this meeting is being held in South Africa, the previous one being ISPPD-2 at Sun City in 2000. Over the past two decades, there have been transformational changes in the control of pneumonia and pneumococcal disease worldwide. This era has been defined by the introduction of pneumococcal conjugate vaccines globally, with a keen focus on assessing vaccine impact and serotype evolution. However, severe outcomes from pneumococcal diseases remain a concern for healthy as well as compromised hosts around the world. What transformational changes will define the next era of pneumococcal disease prevention? This new era will be characterised by a new generation of vaccines and strategies for their use, an improved understanding of genomics, next-generation sequencing, new diagnostics, the role of the microbiome, and better knowledge of host-pathogen interaction. In addition, we invite the submission of topics and research findings related to other, non-pneumococcal causes of pneumonia.

As was done at ISPPD-12, we plan to have an informative and exciting programme that highlights the areas of substantial recent progress while also posing the tough questions where progress has been more challenging. Wherever possible, plenary sessions will take a cross-disciplinary approach to major areas in the field. Parallel sessions will allow us to explore specific topics that cover areas that include but are not limited to clinical and diagnostic issues, host-immune interactions, genomics, immunology, microbiology, epidemiology and the interface between these areas. Meet-the-Expert sessions will provide opportunities for interaction with professionals in smaller, structured settings. Researchers at all levels will have an opportunity to present their work in interactive poster sessions. Attention will be given to how to exchange knowledge and translate findings into policies that benefit individuals affected by or at risk of pneumonia worldwide.

ISPPD-13’s programme will provide ample opportunities for networking professionally and socially. The social programme promises to be exciting and will allow you to experience the culture and warmth of Cape Town. Cape Town is one of the largest cities in South Africa and a thriving multi-cultural metropolis. We look forward to interacting with you as you enjoy the ISPPD-13 Meeting and hopefully spend a few extra days exploring the sights, nature and cuisine of South Africa.

We are delighted to welcome you to Cape Town and South Africa!

Best wishes,

Shabir Madhi, Anne von Gottberg and Mignon du Plessis
ISPPD-13 Co-Chairs, Local Organising Committee

注册费：

* ISPPD members: In order to apply for this category, please ensure your membership is approved before you start the registration process. Registration will not be confirmed otherwise.

** Low and Lower-Middle Income countries: Defined according to the World Bank Country Classification of Low income and Lower – middle income economies; please Click here to see the Country Classification data.

***Trainee (Students/Fellows/Nurses):An official letter of the institution (PDF format), originally stamped and signed by the head of the department confirming this status must be uploaded during the registration process/A copy of your Nurse, AHP ID must be uploaded during the registration process.

FEES FOR IN-PERSON PARTICIPANTS INCLUDE:

• Participation in all scientific sessions (except the Workshops)
• Symposium Material
• Access to the exhibition
• Refreshments as indicated in the scientific programme
• Networking Reception

FEES FOR VIRTUAL PARTICIPANTS INCLUDE:

• Open access to all presentations and session recordings (except the Workshops). Create your own schedule, attend any and all of the sessions whenever and wherever.
• Network with colleagues. Browse a list of participants and click on their name to contact them.
• Earn CME credits. Participate in the scientific program and be eligible to receive the number of CME credits attributed to the virtual meeting.
• Access all the e-posters. Browse research on the hottest topics published in the congress digital abstract book and connect with the abstract authors and other colleagues from around the world through the e-poster virtual consultations.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。